Doptelet (avatrombopag tablets) — Cigna
Thrombocytopenia in a patient with Chronic Liver Disease
Initial criteria
- Patient age ≥ 18 years
- Patient has a current platelet count < 50 x 10^9/L (< 50,000/mcL)
- Patient is scheduled to undergo a procedure within 10 to 13 days after starting Doptelet therapy
Approval duration
5 days